Trial Profile
Efficacy and safety of vildagliptin compared to acarbose in drug naive patients with type 2 diabetes.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Apr 2022
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Acarbose
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 04 May 2012 Actual end date Oct 2006 added as reported by ClinicalTrials.gov.
- 09 Jan 2007 Status change
- 01 Oct 2005 New trial record.